Maravai Lifesciences Holdings (MRVI) Profit After Tax (2020 - 2026)

Maravai Lifesciences Holdings' Profit After Tax history runs 7 years deep, the most recent figure standing at -$3.7 million for Q1 2026.

• In Q1 2026, Profit After Tax rose 92.94% year-over-year to -$3.7 million; the TTM figure through Mar 2026 stood at -$81.7 million (up 53.35% YoY), while the FY2025 annual figure was -$130.8 million, up 9.72% from the prior year.
• Profit After Tax was -$3.7 million for Q1 2026 at Maravai Lifesciences Holdings, down from $37.0 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $146.9 million in Q1 2022 to a low of -$172.5 million in Q3 2024.
• Historically, Profit After Tax has averaged -$5.9 million across 5 years, with a median of -$6.5 million in 2023.
• Biggest YoY gain for Profit After Tax was 162.47% in 2024; the steepest drop was 17926.87% in 2024.
• A 5-year view of Profit After Tax shows it stood at $37.6 million in 2022, then slumped by 392.24% to -$110.0 million in 2023, then jumped by 162.47% to $68.7 million in 2024, then tumbled by 46.19% to $37.0 million in 2025, then tumbled by 110.1% to -$3.7 million in 2026.
• The last three Profit After Tax figures came in at -$3.7 million (Q1 2026), $37.0 million (Q4 2025), and -$45.1 million (Q3 2025), per Business Quant data.